Sustained Revenue GrowthMulti-year revenue growth and a 25% reported revenue growth rate indicate durable expansion of product sales and market penetration. This enlarges scale, supports R&D and capex, and provides a broader base to absorb costs, strengthening long-term business resilience.

Improving Gross MarginsA materially higher gross margin reflects improved manufacturing efficiency or favorable product mix in formulations and APIs. Sustained gross margin expansion enhances the company's ability to fund SG&A and new investments while bolstering structural profitability over the medium term.

Low Financial LeverageLow leverage and a sizable equity base provide financial flexibility to fund growth, absorb regulatory or product setbacks, and pursue inorganic opportunities with less refinancing risk, supporting durable capital structure strength over multiple quarters.

Bears Say

Negative Operating & Free Cash FlowNegative operating and free cash flow signal that reported earnings are not translating into sustainable cash generation. This undermines the firm's ability to self-fund capex, repay obligations, and invest in growth without relying on external financing over the medium term.

Low Net ProfitabilityA modest net margin despite strong top-line growth suggests persistent cost, SG&A, or other non-operating pressures that limit earnings retention. Low net profitability constrains reinvestment, dividend capacity and buffers against pricing or input-cost shocks long-term.

Margin Volatility & Cash Conversion InconsistencyVolatile operating margins and inconsistent Operating Cash Flow to Net Income raise forecasting risk and operational unpredictability. This makes capital planning, investment timing and creditor confidence harder to sustain across multiple quarters.

Unichem Laboratories Limited News

Unichem Laboratories Settles European Commission Fine

Unichem Laboratories Limited ( ($IN:UNICHEMLAB) ) has shared an update. Unichem Laboratories Limited has announced the payment of...

4M ago

Unichem Laboratories Faces Demand Notice from NPPA for Alleged Overcharging

The latest update is out from Unichem Laboratories Limited ( ($IN:UNICHEMLAB) ). Unichem Laboratories Limited has received a...

5M ago

Unichem Laboratories Receives USFDA Inspection Report

Unichem Laboratories Limited ( ($IN:UNICHEMLAB) ) just unveiled an announcement. Unichem Laboratories Limited announced that it has received...

6M ago

Unichem Laboratories Updates RTA Contact Details

Unichem Laboratories Limited ( ($IN:UNICHEMLAB) ) has provided an announcement. Unichem Laboratories Limited announced a change in the...

10M ago

UNICHEMLAB FAQ

What was Unichem Laboratories Limited’s price range in the past 12 months?

Unichem Laboratories Limited lowest stock price was ₹360.55 and its highest was ₹727.95 in the past 12 months.

What is Unichem Laboratories Limited’s market cap?

Unichem Laboratories Limited’s market cap is ₹26.34B.

When is Unichem Laboratories Limited’s upcoming earnings report date?

Unichem Laboratories Limited’s upcoming earnings report date is May 21, 2026 which is in 87 days.

How were Unichem Laboratories Limited’s earnings last quarter?

Unichem Laboratories Limited released its earnings results on Feb 05, 2026. The company reported ₹37.538 earnings per share for the quarter, beating the consensus estimate of N/A by ₹37.538.

Is Unichem Laboratories Limited overvalued?

According to Wall Street analysts Unichem Laboratories Limited’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Unichem Laboratories Limited pay dividends?

Unichem Laboratories Limited pays a Annually dividend of ₹4 which represents an annual dividend yield of N/A. See more information on Unichem Laboratories Limited dividends here

What is Unichem Laboratories Limited’s EPS estimate?

Unichem Laboratories Limited’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Unichem Laboratories Limited have?

Unichem Laboratories Limited has 70,405,754 shares outstanding.

What happened to Unichem Laboratories Limited’s price movement after its last earnings report?

Unichem Laboratories Limited reported an EPS of ₹37.538 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 2.969%.

Which hedge fund is a major shareholder of Unichem Laboratories Limited?

Currently, no hedge funds are holding shares in IN:UNICHEMLAB

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Unichem Laboratories Limited

Unichem Laboratories Limited, a pharmaceutical company, manufactures and sells pharmaceutical products worldwide. It offers formulation products that address various therapeutic areas, such as gastroenterology, cardiology, diabetology, psychiatry, neurology, anti-bacterial, anti-infective, and pain management; and active pharmaceutical ingredients, as well as contract manufacturing services. The company was founded in 1944 and is headquartered in Mumbai, India.